STIMULUS project develops new non-invasive, convenient, low-cost and easy-to-use imaging technology that can measure new digital biomarkers from microcirculation for early detection of cardiovascular diseases. The novel technology will enable earlier detection of heart failure and chronic kidney disease, which will substantially decrease cardiovascular events in the European population.
For both heart failure and chronic kidney disease patients, it is important to diagnose microvascular dysfunction and monitor the deterioration of microvascular function in early phases of the disease progress. Our proposed technology HEMI-speckle system is an integrated solution of two existing prototypes, namely, the multi-spectral optical sensory system and the speckle plethysmography (SPG) system.